Exact Sciences Cuts Loss in Q3 | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences today reported a sharp increase in its revenues for the third quarter and cut its net loss by two-thirds year over year.

The Madison, Wis.-based molecular diagnostics firm reported total revenues of $1.3 million for the three-month period ended Sept. 30. It brought in product royalty revenues of $9,000 and license fees of $1.2 million, compared to license fees of $337,000 in the third quarter of 2008. In addition, in last year's third quarter the company paid out $1 million in royalty fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.